Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 12/2013

01-12-2013 | Original Article

The characteristics of ascites in patients with POEMS syndrome

Authors: Rong Tai Cui, Sheng Yuan Yu, Xu Sheng Huang, Jia Tang Zhang, Fei Li, Chuan Qiang Pu

Published in: Annals of Hematology | Issue 12/2013

Login to get access

Abstract

The characteristics of ascites in patients with POEMS syndrome, which comprise polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes, are unknown. We described the frequency of ascites at presentation of POEMS syndrome and further evaluated for the pathogenesis and nature of the ascites. One hundred and six consecutive patients with POEMS syndrome in Chinese PLA General Hospital were evaluated for the presence of ascites, and the cellular and biochemical characteristics of the ascitic fluids were assessed. Serum levels of complement, cytokines, and clinical chemistry parameters were analyzed in peripheral blood samples of the patients with POEMS syndrome. Ascites was observed in 42 of 106 (39.6 %) patients with POEMS syndrome. Patients with ascites had significantly high serum levels of C3 and C4 complement components and TNF-α (all p < 0.01). In 31 (73.8 %) patients who underwent paracentesis, the ascitic fluids had low serum ascites albumin gradients (SAAG), indicating non-portal hypertension. Spontaneous bacterial peritonitis was not observed. Ascites is a common complication of POEMS syndrome and has characteristics of non-portal hypertension, based on low SAAG. Increased immune activation and inflammatory status could contribute to the pathogenesis of ascites in POEMS syndrome.
Literature
1.
Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E et al (1984) The Crow–Fukase syndrome: a study of 102 cases in Japan. Neurology 34:712–720PubMedCrossRef
2.
Cui RT, Huang XS, Shi Q, Tian CL, Liu JX, Pu CQ (2011) POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome in China. Intern Med J 41:481–485PubMedCrossRef
3.
Bardwick PA, Zveifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL (1980) Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes: the POEMS syndrome. Medicine 59:311–322PubMedCrossRef
4.
Dispenzieri A (2012) POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol 87:804–814PubMedCrossRef
5.
Singh D, Wadhwa J, Kumar L, Raina V, Agarwal A, Kochupillai V (2003) POEMS syndrome: experience with fourteen cases. Leuk Lymphoma 44:1749–1752PubMedCrossRef
6.
Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR et al (2003) POEMS syndrome: definitions and long-term outcome. Blood 101:2496–2506PubMedCrossRef
7.
Higuchi M, Kamijo H, Koyama T, Kaneko Y, Kamijo Y, Kobayashi N et al (2003) POEMS syndrome caused refractory ascites in a polycystic disease patient undergoing hemodialysis. Clin Exp Nephrol 7:301–305PubMedCrossRef
8.
Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M et al (1998) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow–Fukase (POEMS) syndrome. Muscle Nerve 21:1390–1397PubMedCrossRef
9.
Yamada Y, Sawai S, Misawa S, Kanai K, Shibuya K, Mori M et al (2013) Multiple angiogenetic factors are upregulated in POEMS syndrome. Ann Hematol 92:245–248PubMedCrossRef
10.
Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr (1972) Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 77:507–513PubMedCrossRef
11.
Nakazawa K, Itoh N, Shigematsu H, Koh CS (1992) An autopsy case of Crow–Fukase (POEMS) syndrome with a high level of IL-6 in the ascites. Special reference to glomerular lesions. Acta Pathol Jpn 42:651–656PubMed
12.
Bocsi J, Hambsch J, Osmancik P, Schneider P, Valet G, Tarnok A (2002) Preoperative prediction of pediatric patients with effusions and edema following cardiopulmonary bypass surgery by serological and routine laboratory data. Crit Care 6:226–233PubMedCrossRef
13.
Dyck PJ, Engelstad J, Dispenzieri A (2006) Vascular endothelial growth factor and POEMS. Neurology 66:10–12PubMedCrossRef
14.
Scarlato M, Previtali SC (2011) POEMS syndrome: the matter-of-fact approach. Curr Opin Neurol 24:491–496PubMedCrossRef
15.
Gherardi RK, Bélec L, Fromont G, Divine M, Malapert D, Ganlard P et al (1994) Elevated levels of interleukin-1β (IL-1β) and IL-6 in serum and increased production of IL-1β mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood 83:2587–2593PubMed
16.
D’Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA et al (2011) The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood 118:4663–4665PubMedCrossRef
17.
Mineta M, Hatori M, Sano H, Hosaka M, Kokubun S, Hiroki E et al (2006) Recurrent Crow–Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: a case report and review of the literature. Tohoku J Exp Med 210:269–277PubMedCrossRef
18.
Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R et al (2005) Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 128(pt 8):1911–1920PubMedCrossRef
19.
Yamada Y, Sawai S, Misawa S, Kanai K, Shibuya K, Mori M et al (2013) Multiple angiogenetic factors are upregulated in POEMS syndrome. Ann Hematol 92:245–248PubMedCrossRef
20.
Chimenti MS, Ballanti E, Perricone C, Cipriani P, Giacomelli R, Perricone R (2013) Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways. Autoimmun Rev 12:599–606PubMedCrossRef
21.
Szczygiel AM, Brzezinka G, Targosz-Korecka M, Chlopicki S, Szymonski M (2012) Elasticity changes anti-correlate with NO production for human endothelial cells stimulated with TNF-α. Pflugers Arch 463:487–496PubMedCrossRef
22.
Nobile-Orazio E, Terenghi F, Giannotta C, Gallia F, Nozza A (2009) Serum VEGF levels in POEMS syndrome and immune-mediated neuropathies. Neurology 72:1024–1026PubMedCrossRef
Metadata
Title
The characteristics of ascites in patients with POEMS syndrome
Authors
Rong Tai Cui
Sheng Yuan Yu
Xu Sheng Huang
Jia Tang Zhang
Fei Li
Chuan Qiang Pu
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 12/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1829-7

Other articles of this Issue 12/2013

Annals of Hematology 12/2013 Go to the issue

Original Article

Depression in subjects with beta-thalassemia minor

Original Article

Comparison and modelling of pegylated or unpegylated G-CSF schedules in CHOP-14 regimen of elderly patients with aggressive B-cell lymphoma

Original Article

Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemia

Original Article

Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis

Original Article

Clonal chromosomal abnormalities in Philadelphia-negative cells in chronic myeloid leukemia patients treated with nilotinib used in first-line therapy

Original Article

Storage time of red blood cell concentrates and adverse outcomes after cardiac surgery: a cohort study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits